- Details
-
Published: Tuesday, September 06 2022 00:01
In the world of startups, opportunity can come knocking in strange ways. Six years ago, Didier Depireux (Ph.D. β91, physics) was doing research at the University of Maryland when he was approached by Sam Owen, a young scientist who said heβd developed a device to treat motion sickness. Depireux was skeptical but decided to check it out.
βSince I get very severe motion sickness, I made a deal with him,β Depireux recalled. βI said, βIβll come over with my car and you can drive me around while I use the device. If I havenβt thrown up after 20 minutes while Iβm in the back of the car reading, Iβll join the effort.ββ
The two made plans to meet in Washington, D.C., on a muggy July afternoon.
Didier Depireux
βSo, I go to Georgetown. The windows are down, itβs hot, itβs humid and Iβm thinking I will not make it past the first turn,β Depireux explained. βOwen is driving and Iβm in the back seat using his device and reading my cellphone. And for the first time in my lifeβand Iβm over 50 years oldβI was able to read in the back of a car and not get sick. I thought, βI need to join this, this is amazing.ββ
Thanks to that strange summer ride-along, Depireux joined Owen in launching a startup called Otolith Labs to address inner ear-related conditions and their often debilitating symptoms. Otolithβs noninvasive vestibular system masking technologyβdesigned for acute treatment of vestibular vertigoβreceived the FDAβs Breakthrough Device designation and clinical trials are ongoing, with support from investors including AOL founder Jack Davies and billionaire entrepreneur Mark Cuban.
All of this sets the stage for a major test that could lead to the startupβs ultimate goalβFDA approval as early as next year.
βIn July we told the FDA we want to do a large-scale pivotal trial with hundreds of participants,β Depireux explained. βIf all goes well, weβll have a meeting next summer where the FDA will approve us and then the device will become available.β
For Depireux, itβs the latest step on a bigger mission that has guided his career.
Didier DepireuxβItβs mostly relevance,β he explained. βI would like my life to make a difference, thatβs the one thing that keeps me going.β
From philosophy to physics
Depireux was raised in Belgium. A bright, thoughtful boy, he grew up with a strong interest in science and theory, thanks to his father, a physics professor, and his mother, a chemistry teacher.
βI was always very science-y,β Depireux recalled. βInitially, I wanted to become a philosopher and I read this 800-page bookβI think it was Kantβand at the end of it I was like, βI still donβt know the answer, and Iβm not even sure I understand the question anymore.β Thatβs when I thought thatβs not a good fit for me.β
Depireux eventually gravitated toward physics. After receiving his B.S. in physics from the University of Liège in Belgium in 1986, he began his graduate work in physics at the University of Maryland, where he focused on string theory and met Distinguished University Professor of Physics Sylvester James Gates Jr., who quickly became a mentor and friend.
βJim had a huge impact on me. He was a fantastic person to work with and he had so much positive energy,β Depireux said. βI still remember late one night I was working on something, and I was stuck and I wrote to him, and he said, βIβll come over, letβs work this out.β So we had office hours at 10:30 p.m. just because I couldnβt solve a problem.β
Depireux earned his Ph.D. in 1991 and went on to do postdoctoral work in Quebec, Canada, before returning to College Park in 1994. Inspired by his wife Pamela, who was getting her Ph.D. in neuropharmacology, Depireux took on the challenge of modeling the brain and studying how it processes sound. By 2001, he was also teaching a gross anatomy class at the University of Maryland School of Medicine.
βI think, to this day, I am the only string theorist who has taught gross anatomy,β he reflected.
From his research on the brain and hearing, Depireux shifted his focus to tinnitusβdisruptive ringing in the ears. He explored possible treatments and eventually teamed up with former UMD Bioengineering Professor Benjamin Shapiro who was already working on the drug delivery challenges Depireux was trying to solve.
βI wanted to get drug delivery to the ear but I didnβt know how to do it,β Depireux said. βHe had this method with nanoparticles to deliver drugs and I had the target so we started working together.β
In 2013, the two launched Otomagnetics, a startup that has made major strides in developing noninvasive methods to treat inner ear diseases and more.
βWeβve gotten very nice results as far as drug delivery goes and Otomagnetics is still an ongoing concern,β Depireux explained, βBut raising money for drug delivery is the real challenge, because to get drug delivery to the ear is going to take hundreds of millions of dollars, and that hasnβt happened yet.β
Going all-in on Otolith
Depireux balanced his time between Otomagnetics, his UMD research and teaching at the School of Medicine until 2016, when he experienced Owenβs experimental motion sickness device for the first time. Depireux saw so much potential with the device that he went all-in on Otolith.
βYou have to have pretty strong resilience to join a startupβI went for a year and a half without a salary or anything,β Depireux explained. βItβs not like we didnβt have money, we just needed all of the money to develop the device, get the patents in, all of the things we had to do.β
Though Otolith started with a motion sickness device, its co-founders hoped to make an even bigger impact by developing a device for vertigo, debilitating dizziness often caused by problems in the inner ear.
And they had a plan.
βFor tinnitus or ringing in the ears, some patients get relief from a noise maskerβthey can still perceive their tinnitus, but the noise masker allows them to ignore the tinnitus,β Depireux explained. βSo Sam, my cofounder said, βWhy donβt we come up with a noise masker for the vestibular system?ββ
Thatβs exactly what they did. Their novel device, worn like a headband, treats vertigo by applying localized mechanical stimulation to the vestibular system through calibrated vibrations.
Depireux says he never would have made it this far without physics.
βMy physics training really helped me,β he explained. βIn physics, you have this huge problem and you have to break it down. If itβs intractable, you make it tractable, break it into small, simple things we can understand and then we can solve it.β
Promising results and personal stories
Clinical trials of Otolithβs investigational headband have yielded promising results. In the first of a series of ongoing clinical studies, 87.5% of the 40 participants reported a reduction in their vertigo within five minutes of turning on the device. But for Depireux, itβs the personal stories that are most rewarding.
βSomehow my phone number was listed as an emergency contact on clinicaltrials.gov, which I thought would be for emergencies only,β he said. βIβd have patients calling me in tears, telling me, βWhen my grandkids visit, I can finally bend down and pick them up, and it used to be that just bending down would send me into such vertigo that I would have to go to bed for days.β Or βFor the first time in years, Iβve been able to walk around the block.β Thatβs what really motivates me.β
It's been Depireuxβs goal all alongβdoing relevant research that changes peopleβs lives.
βWe cannot help 100% of vertigo patients, no device does that,β he reflected. βBut if we can help even half of those patients, thatβs really my hope.β
Looking back on a career path thatβs been anything but predictable, Depireux appreciates every challenge and setback that got him to where he is today.
βSomething can feel like a failure when things go wrong, but then later you realize you really learned something from it,β he reflected. βIβm so grateful I was given the opportunity to come to the U.S. and study physics and do research in College Park, do this random walk in my career and finally end up doing something that I feel has given me great meaning in my life.β
Written by Leslie Miller